KDR and neoplasm: However, a caveat of the Vijay Avin et al study was that animal model used did not allow an assessment of the role of SIPR1 enhancement of VEGFR2 angiogenic signaling in promoting tumor resistance to VEGFR2 based therapy which represent an attractive topic for future investigations.